Octave Specialty (OSG) Cash & Equivalents (2010 - 2026)

Octave Specialty's Cash & Equivalents history runs 17 years deep, the most recent figure standing at $93.5 million for Q1 2026.

• On a quarterly basis, Cash & Equivalents rose 81.06% year-over-year to $93.5 million in Q1 2026; TTM through Mar 2026 was $93.5 million, a 81.06% increase from a year earlier, with the FY2025 full-year figure at $68.4 million, up 44.77% from the prior year.
• Cash & Equivalents improved to $93.5 million in Q1 2026 per OSG's latest filing, from $68.4 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $309.0 million in Q2 2023 and bottomed at $19.2 million in Q4 2023.
• The 5-year median for Cash & Equivalents is $51.7 million (2025), against an average of $94.9 million.
• Across the five-year window, Cash & Equivalents jumped 694.74% in 2023 and plunged 91.88% in 2024, its largest moves.
• Year by year, Cash & Equivalents stood at $19.9 million in 2022, then dropped by 3.6% to $19.2 million in 2023, then jumped by 145.93% to $47.3 million in 2024, then jumped by 44.77% to $68.4 million in 2025, then soared by 36.67% to $93.5 million in 2026.
• Per Business Quant, the three latest OSG Cash & Equivalents figures stand at $93.5 million (Q1 2026), $68.4 million (Q4 2025), and $51.8 million (Q3 2025).